Technology
Health
Biotechnology

Kazia Therapeutics

$2.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (13.20%) Today
$0.00 (0.00%) As of 9:30 AM EDT after-hours

Why Robinhood?

You can buy or sell KZIA and other stocks, options, ETFs, and crypto commission-free!

About KZIA

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. Read More The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Employees
Headquarters
Sydney, New South Wales (NSW)
Founded
1994
Market Cap
17.59M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.11K
High Today
$2.83
Low Today
$2.83
Open Price
$2.83
Volume
9.00
52 Week High
$4.27
52 Week Low
$2.04

Collections

Technology
Health
Biotechnology
Therapy
Pharmaceutical
Cancer Prevention
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.